Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effectiveness and safety of topiramate as monotherapy for recently diagnosed partial-onset seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures
• Seizures

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Epilepsies, Partial | Phase 3 | Status: COMPLETED